PRimary IndividualiZed Evaluation of Cardiovascular Events in Patients With Diabetes Mellitus Using hemoTAG
NCT06567795 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 189
Last updated 2024-08-23
Summary
To evaluate the proportion of diabetic mellitus patients with CV events as measured by HEMOTAG.
Conditions
- Diabetes Mellitus Type 2
- Cardiovascular Diseases
- Coronary Artery Disease
- Cerebrovascular Disease
- Peripheral Artery Disease
Interventions
- DEVICE
-
Hemotag
Hemotag non-invasive medical device is used to see cardiac function for DM2 patients at-home for 30 days
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Aventusoft, LLC.
lead INDUSTRY
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-03-14
- Primary Completion
- 2026-03-18
- Completion
- 2027-03-18
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Myocardial Perfusion in Type 2 Diabetes
NCT01043965 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Personalizing A1c Using Hematologic Indices and CGM for Accurate Diabetes Diagnosis
NCT07111416 ·Status: NOT_YET_RECRUITING
-
SomaSignal Tests on Medical Management and Change in Risk in Patients With Diabetes
NCT05256706 ·Status: COMPLETED ·Phase: NA
-
NT-ProBNP-based Heart Failure Screening and Prevention Trial in Patients With Type 2 Diabetes: STRONG-DM Study
NCT06593327 ·Status: RECRUITING ·Phase: NA
-
Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2D
NCT00041405 ·Status: COMPLETED
-
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
NCT00021944 ·Status: COMPLETED
-
DETECT-Diabetes Cardiovascular Risk-Evaluation: Targets and Essential Data for Commitment of Treatment
NCT01076608 ·Status: COMPLETED
-
Plaque Composition in T2DM With and Without Microvascular Complications
NCT06439719 ·Status: NOT_YET_RECRUITING
-
PBMC as Biomarkers of Diabetic Cardiomyopathy
NCT05651919 ·Status: RECRUITING
-
A Study of People With Type 2 Diabetes Who Have Diseases That Affect the Heart and Blood Vessels. The Study Will Also Look at the Treatment of a Group of These People in Hospitals in Portugal
NCT03797885 ·Status: COMPLETED
-
Resistant Hypertension in Patients With Type-II-Diabetes Mellitus
NCT01056367 ·Status: COMPLETED
-
Cardiac Function and Microcirculation: Type 2 DIABetes and ECHOcardiographic Changes Over Time
NCT02956577 ·Status: COMPLETED
-
Coronary Artery Calcium-guided Primary Prevention of Major Coronary Heart Disease in Asymptomatic Diabetes
NCT05267990 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Evaluation of SCOUT DS in Subjects With Type 2 Diabetes #2
NCT01346046 ·Status: COMPLETED
-
Association of Triglyceride Glucose Index and HOMA IR as Predictors of Vascular Complications of DM Type 2
NCT05695651 ·Status: UNKNOWN
-
Magnetocardiography Endocrine Registry
NCT04739254 ·Status: SUSPENDED
-
EValuation Of poLygenic Scores and CT imAging In Risk Factor Modification in Patients With diabEtes
NCT07091162 ·Status: RECRUITING ·Phase: NA
-
Effect the Glycemic Control on Cardiac Function
NCT06761820 ·Status: NOT_YET_RECRUITING
-
Pragmatic Impact of Proteomic Risk Stratification in Diabetes Mellitus
NCT05182359 ·Status: COMPLETED ·Phase: NA
-
Effect of Patient Management Based on Continuous Continuous Glucose Monitoring on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes and Moderate to Severe Coronary Artery Stenosis
NCT06060483 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Subjects With T2D or at Risk of T2D Cohort Follow-up
NCT05567692 ·Status: SUSPENDED
-
Macrophage Phenotype in Type 2 Diabetics After Myocardial Infarction and the Potential Role of miRNAs Secreted
NCT02768935 ·Status: COMPLETED ·Phase: NA
-
Prognosis of Type 2 Diabetic Patients
NCT01426685 ·Status: UNKNOWN
-
Glucose Monitoring After Acute Myocardial Infarct in People With Diabetes
NCT05431296 ·Status: RECRUITING ·Phase: NA
-
Metabolic Causes of Thrombosis in Type 2 Diabetes Mellitus
NCT00829699 ·Status: COMPLETED ·Phase: EARLY_PHASE1